Erlotinib - Astellas Pharma/Roche
At a glance
- Drug Originator OSI Pharmaceuticals
- Drug Licenced by Chugai Pharmaceutical; Genentech; Roche
- Drug Class Alkynes; Antineoplastics; Quinazolines; Skin disorder therapies; Small molecules
- Mechanism of Action Epidermal growth factor receptor antagonists
- USA Patent Applicants OSI PHARMS
- USA Patents 4
- NDAs 1
- Patent Applications 4,270
Table of Contents

Disclaimer